Annual CFF
$13.95 M
-$221.13 M-94.07%
31 December 2023
Summary:
Inspire Medical Systems annual cash flow from financing activities is currently $13.95 million, with the most recent change of -$221.13 million (-94.07%) on 31 December 2023. During the last 3 years, it has fallen by -$120.11 million (-89.59%). INSP annual CFF is now -94.07% below its all-time high of $235.08 million, reached on 31 December 2022.INSP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$9.89 M
+$2.80 M+39.55%
30 September 2024
Summary:
Inspire Medical Systems quarterly cash flow from financing activities is currently $9.89 million, with the most recent change of +$2.80 million (+39.55%) on 30 September 2024. Over the past year, it has increased by +$6.39 million (+182.57%). INSP quarterly CFF is now -95.59% below its all-time high of $224.13 million, reached on 30 September 2022.INSP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$7.63 M
+$6.39 M+515.32%
30 September 2024
Summary:
Inspire Medical Systems TTM cash flow from financing activities is currently $7.63 million, with the most recent change of +$6.39 million (+515.32%) on 30 September 2024. Over the past year, it has dropped by -$23.72 million (-75.66%). INSP TTM CFF is now -96.97% below its all-time high of $251.98 million, reached on 30 June 2023.INSP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INSP Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -94.1% | +182.6% | -75.7% |
3 y3 years | -89.6% | +157.3% | -50.4% |
5 y5 years | -92.7% | +5051.0% | -89.3% |
INSP Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -94.1% | at low | -95.6% | +197.8% | -97.0% | +515.3% |
5 y | 5 years | -94.1% | +610.3% | -95.6% | +197.8% | -97.0% | +515.3% |
alltime | all time | -94.1% | +610.3% | -95.6% | +197.8% | -97.0% | +515.3% |
Inspire Medical Systems Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $9.89 M(+39.6%) | $7.63 M(+515.3%) |
June 2024 | - | $7.09 M(+822.8%) | $1.24 M(-86.4%) |
Mar 2024 | - | $768.00 K(-107.6%) | $9.09 M(-34.9%) |
Dec 2023 | $13.95 M(-94.1%) | -$10.12 M(-389.0%) | $13.95 M(-55.5%) |
Sept 2023 | - | $3.50 M(-76.6%) | $31.35 M(-87.6%) |
June 2023 | - | $14.93 M(+165.2%) | $251.98 M(+6.0%) |
Mar 2023 | - | $5.63 M(-22.7%) | $237.66 M(+1.1%) |
Dec 2022 | $235.08 M(+1472.6%) | $7.29 M(-96.7%) | $235.08 M(+1.4%) |
Sept 2022 | - | $224.13 M(>+9900.0%) | $231.86 M(+1901.9%) |
June 2022 | - | $619.00 K(-79.7%) | $11.58 M(-19.8%) |
Mar 2022 | - | $3.04 M(-25.3%) | $14.44 M(-3.4%) |
Dec 2021 | $14.95 M(-88.9%) | $4.08 M(+6.1%) | $14.95 M(-2.9%) |
Sept 2021 | - | $3.84 M(+10.5%) | $15.39 M(+11.0%) |
June 2021 | - | $3.48 M(-2.0%) | $13.86 M(-89.9%) |
Mar 2021 | - | $3.55 M(-21.5%) | $136.83 M(+2.1%) |
Dec 2020 | $134.06 M | $4.52 M(+95.5%) | $134.06 M(+2.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2020 | - | $2.31 M(-98.2%) | $130.44 M(+1.7%) |
June 2020 | - | $126.44 M(>+9900.0%) | $128.32 M(+4016.8%) |
Mar 2020 | - | $787.00 K(-12.3%) | $3.12 M(+58.7%) |
Dec 2019 | $1.96 M(-99.0%) | $897.00 K(+367.2%) | $1.96 M(-97.2%) |
Sept 2019 | - | $192.00 K(-84.5%) | $70.98 M(+0.2%) |
June 2019 | - | $1.24 M(-439.1%) | $70.83 M(-61.0%) |
Mar 2019 | - | -$366.00 K(-100.5%) | $181.83 M(-4.5%) |
Dec 2018 | $190.38 M(+641.9%) | $69.91 M(>+9900.0%) | $190.38 M(+57.8%) |
Sept 2018 | - | $46.00 K(-100.0%) | $120.61 M(-0.0%) |
June 2018 | - | $112.24 M(+1271.3%) | $120.65 M(+1334.0%) |
Mar 2018 | - | $8.19 M(+5746.4%) | $8.41 M(-67.2%) |
Dec 2017 | $25.66 M(+100.3%) | $140.00 K(+62.8%) | $25.66 M(+0.5%) |
Sept 2017 | - | $86.00 K(+2766.7%) | $25.52 M(+0.3%) |
June 2017 | - | $3000.00(-100.0%) | $25.43 M(+0.0%) |
Mar 2017 | - | $25.43 M | $25.43 M |
Dec 2016 | $12.81 M(+404.1%) | - | - |
Dec 2015 | $2.54 M | - | - |
FAQ
- What is Inspire Medical Systems annual cash flow from financing activities?
- What is the all time high annual CFF for Inspire Medical Systems?
- What is Inspire Medical Systems annual CFF year-on-year change?
- What is Inspire Medical Systems quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Inspire Medical Systems?
- What is Inspire Medical Systems quarterly CFF year-on-year change?
- What is Inspire Medical Systems TTM cash flow from financing activities?
- What is the all time high TTM CFF for Inspire Medical Systems?
- What is Inspire Medical Systems TTM CFF year-on-year change?
What is Inspire Medical Systems annual cash flow from financing activities?
The current annual CFF of INSP is $13.95 M
What is the all time high annual CFF for Inspire Medical Systems?
Inspire Medical Systems all-time high annual cash flow from financing activities is $235.08 M
What is Inspire Medical Systems annual CFF year-on-year change?
Over the past year, INSP annual cash flow from financing activities has changed by -$221.13 M (-94.07%)
What is Inspire Medical Systems quarterly cash flow from financing activities?
The current quarterly CFF of INSP is $9.89 M
What is the all time high quarterly CFF for Inspire Medical Systems?
Inspire Medical Systems all-time high quarterly cash flow from financing activities is $224.13 M
What is Inspire Medical Systems quarterly CFF year-on-year change?
Over the past year, INSP quarterly cash flow from financing activities has changed by +$6.39 M (+182.57%)
What is Inspire Medical Systems TTM cash flow from financing activities?
The current TTM CFF of INSP is $7.63 M
What is the all time high TTM CFF for Inspire Medical Systems?
Inspire Medical Systems all-time high TTM cash flow from financing activities is $251.98 M
What is Inspire Medical Systems TTM CFF year-on-year change?
Over the past year, INSP TTM cash flow from financing activities has changed by -$23.72 M (-75.66%)